Lyssavirus, e.g. rabies virus

Full Title

ssRNA viruses negative-sense > Details > Rhabdoviridae > Lyssavirus, e.g. rabies virus

Child Classifications

Navigate with arrow keys, Enter to open

• C12N 2760/20121 Viruses as such, e.g. new isolates, mutants or their genomic sequences
• C12N 2760/20122 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
• C12N 2760/20123 Virus like particles [VLP]
• C12N 2760/20131 Uses of virus other than therapeutic or vaccine, e.g. disinfectant
• C12N 2760/20132 Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
• C12N 2760/20133 Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
• C12N 2760/20134 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
• C12N 2760/20141 Use of virus, viral particle or viral elements as a vector
• C12N 2760/20151 Methods of production or purification of viral material
• C12N 2760/20161 Methods of inactivation or attenuation
• C12N 2760/20171 Demonstrated in vivo effect
• C12N 2760/20188 for redistribution